Nykode Therapeutics Share Price
Stocks
VACC
NO0010714785
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.040 NOK | -2.56% |
|
-5.59% | +26.04% |
| 05-27 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-27 | Nykode Therapeutics AS, Q1 2026 Earnings Call, May 27, 2026 |
| Market Cap | 1.02B 104M 91.03M 83.89M 77.76M 148M 9.87B 150M 1.01B 391M 4.87B 391M 382M 16.84B | P/E 2026 * |
-4.83x | P/E 2027 * | -33.7x |
|---|---|---|---|---|---|
| Enterprise Value | 534M 54.49M 47.69M 43.95M 40.73M 77.33M 5.17B 78.57M 527M 205M 2.55B 205M 200M 8.82B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 2.73x |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nykode Therapeutics
| 1 day | -2.56% | ||
| 1 week | -5.59% | ||
| Current month | -5.59% | ||
| 1 month | -4.25% | ||
| 3 months | -6.32% | ||
| 6 months | +33.69% | ||
| Current year | +26.04% |
| 1 week | 3.04 |  | 3.29 |
| 1 month | 3.04 | | 3.3 |
| Current year | 2.21 | | 4.1 |
| 1 year | 1.44 | | 4.1 |
| 3 years | 1.44 | | 30.18 |
| 5 years | 1.44 | | 85.3 |
| 10 years | 1.44 | | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Engsig
CEO | Chief Executive Officer | 54 | 31/12/2018 |
| President | 49 | 31/12/2016 | |
Harald Gurvin
DFI | Director of Finance/CFO | 51 | 02/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
Trygve Lauvdal
BRD | Director/Board Member | 57 | - |
Susanne Stuffers
CHM | Chairman | 45 | 22/04/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/03/25 | Buy | Company | 3,000,000 | 0.9187% | ||
| 19/12/24 | Sell | Director | 100,000 | 0.0306% | ||
| 19/12/24 | Buy | Director | 100,000 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.56% | -5.59% | +65.40% | -88.21% | 104M | |
| -0.10% | +0.10% | +74.33% | +133.26% | 57.73B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 54.69B | |
| +0.75% | +1.68% | -14.03% | -11.46% | 23.75B | |
| +2.17% | +6.11% | +16.69% | +469.66% | 24.18B | |
| -2.70% | +4.25% | +40.38% | -3.72% | 19.82B | |
| +3.78% | +5.65% | +44.99% | -26.23% | 17.14B | |
| +3.46% | +17.72% | +206.66% | +364.07% | 16.75B | |
| -1.81% | +18.00% | +41.99% | - | 15.57B | |
| +3.06% | +5.58% | +30.08% | +197.49% | 13.96B | |
| Average | +0.22% | +4.80% | +57.35% | +124.58% | 24.37B | |
| Weighted average by Cap. | -0.24% | +3.33% | +58.03% | +139.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 162M 16.51M 14.45M 13.31M 12.34M 23.43M 1.57B 23.81M 160M 62.09M 773M 61.98M 60.64M 2.67B |
| Net income | -208M -21.23M -18.58M -17.12M -15.87M -30.12M -2.01B -30.61M -205M -79.83M -994M -79.69M -77.97M -3.44B | -41.58M -4.25M -3.72M -3.42M -3.17M -6.02M -403M -6.12M -41.05M -15.97M -199M -15.94M -15.59M -687M |
| Net Debt | -485M -49.53M -43.34M -39.94M -37.02M -70.28M -4.7B -71.42M -479M -186M -2.32B -186M -182M -8.02B | -578M -58.96M -51.6M -47.55M -44.08M -83.67M -5.6B -85.02M -570M -222M -2.76B -221M -217M -9.55B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | NOK 3.040 | -2.56% | 408,897 |
| 06/07/26 | NOK 3.120 | +1.46% | 349,273 |
| 03/07/26 | NOK 3.075 | -2.07% | 115,101 |
| 02/07/26 | NOK 3.140 | +1.95% | 311,061 |
| 01/07/26 | NOK 3.080 | -4.35% | 534,664 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VACC Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
